PCT Vs. Paris Convention: Which route fits your business strategy best?
Introduction : The Cross-Border patent process is a costly and complex business. Innovators often think of choosing a foreign filing route as a box to check or a procedure to follow. What is actually viewed as a choice between patent protection under the Patent Cooperation Treaty (PCT) or the Paris Convention, is actually a basic business decision. Your decision impacts on your corporate cash flow, runway, the time it takes to validate your product in the market, and your final valuation.
A bad timing or structure in this stage can lead to the premature use up of a startup’s capital or to the unintentionally lost rights in pivotal countries. This blog will give a sober and honest analysis of both routes from the legal, financial and strategic perspectives. We examine the significant international treaties, understand the stringent national provisions in great detail (with particular focus on the Indian Patent regime) and will provide you with a practical decision-making tool to maximize your global intellectual property (IP) portfolio.
Legal Provisions
Patent prosecution work in the International arena is conducted in a regulated legal environment. The articles of the treaty and the domestic regulations may be very important to avoid a loss of priority rights to the extent of catastrophe. The 12-month Priority right, as per;
- Paris Convention, Art. 4 : Under the Paris Convention for the protection of the Industrial property (1883) the principle of the Right of Priority is the Foundation. Mechanism: Applicant submits a patent application in a member state (the “home” application), and has 12 months from the home application date to file the other applications in the other member states.
- Legal effect: These subsequent foreign filings will have the priority date of the initial filing. The insurer is protected from intervening prior art or public disclosure in the 12 months before the effective filing date of the application.
- Patent Cooperation Treaty (PCT), Arts. 3,4,8 : The PCT (1970) is administered by the World Intellectual Property Organization (WIPO), which streamlines the first steps in the process of international filing.
- The International Application is divided into the following sections : Article 3 & 4: Govern the structure of the International Application. Only one filing, uniform in form such as request, description, claims and abstract, is recognized throughout all 158+ contracting states.
- Article 8 : makes the international application binding with one or more of the earlier applications filed in a country party to the Paris Convention, explicitly claiming the priority of the earlier applications.
PCT, Arts. The National Phase Entry Deadlines are 22/39.
The PCT is not a patent grant for a "global patent". Rather, it generates an international phase, which gets broken up into national applications. Article 22: Applicants must present a translation (where required) and pay the national fees to the designated patent offices within 30 months of the priority date.
Article 39: If the applicant chooses to have the case examined under the optional international preliminary examination provisions of Chapter II of the treaty, the time period is extended to 30 months (or 31 months in many jurisdictions).
The Patents Act, 1970 and Patent Rules, India provide specific provisions for India.
Local statutory limits are paramount in these international routes : Rule 20(4)(i) of the Patent Rules, 2003 clearly provides that the Indian National Phase entry from PCT application is limited to 31 months from the earliest priority date.
Request for Examination (RFE) : Rules 24B and Section 11B of Patents Act, 1970. As per the transformative Amendments to Patent Rules 2024, which came into effect on 15 March 2024, the RFE (Form 18/18A) is supposed to be filed within 31 months from the priority date (as in the national phase).
Section 39 : If a patent application is filed abroad without a Foreign Filing License (FFL) on Form 25, it shall be rejected if an Indian patent application is pending for a period of not less than 6 weeks before filing abroad, and there are no secrecy directions issued.
Legal analysis
Filtering: 12-month window vs. 31-month deferred decision
The fundamental difference between two ways is the manipulation of time.
The Paris Convention provides for a timeframe of only 12 months from filing to complete the worldwide strategy, identify the countries of interest, engage foreign counsel, translate specifications, and complete filing.
Cost : Single PCT Filing Vs. Simultaneous Paris Filings
These routes have very different financial paths. The Paris Convention has low up-front costs, but a big cost surge at 12 months. The PCT asks for a larger upfront cost, but has the advantage of pushing back a large amount of foreign capital spending by more than one-and-a-half years.
| Basis | Paris Convention | PCT Route (International Phase + National Phase Entry) |
Upfront Treaty / Filing Fees | Low (Only local home country filing fee needed) | High (WIPO International filing fee, transmittal fee and search fee) |
Your Year 1 Costs (at Month 12) | Extreme Cost Spike: Simultaneous foreign attorney fees, local translations, and official filing fees in all 4 countries. | Minimal: No national filing fee; just the international application is maintained. |
Year 2.5 Costs (at Month 30/31 | Minimal: Only local prosecution costs that are required to be paid on an ongoing basis. | Deferred Cost Spike: fees for translation, foreign associate and fees for national phase entry (e.g., India Form 1 + India Form 18). |
Translation & Counsel Costs | Must be paid completely within 12 months. | Fully deferred until 30/31 months; absolutely avoided by countries removed from the list. |
Flexibility: Market Validation and PCT Chapter II Amendments
The longer the PCT, the more cushion businesses have. The international phase takes 18 months where a company can pitch investors, fundraise and test market interest, or even change product designs.
In addition, PCT Chapter II (Demand for International Preliminary Examination) allows applicants to modify their claims before WIPO. This enables them to respond to negative search reports centrally, allowing them to enter the national phase with a cleaner and stronger set of claims which can be processed quicker in local examination.
Strategic Use: Delay Itself is the Strategic Asset
Time is equity for an enterprise. By using the PCT, capital is not tied up in the early development process, where the risk is highest. During these 30 months, if an international market becomes commercially unimportant or another competitor is first to market in a particular market, you can simply remove that country from your national phase road map.
Relevant Case Laws and Precedents
The Indian Judiciary and Indian Patent Office (IPO) sees overseas deadlines as inviolable walls that cannot be crossed. Recent case law shows the importance of the procedural irregularities that occur during the national phase entry and the consequences thereof: the loss of the right will not be restored.
Neurocentria Inc. v Deputy Controller of Patents & Designs (Delhi High Court, 2026)
In this benchmark decision (C.A. (COMM. IPD-PAT) 5/2025) was an applicant based in California (U.S.) who failed to file within the 31-month time for entry into the national phase in India. They tried to avoid this by filing the application months late, and deliberately omitting the earliest priority date from Form 1 so that the filing date would be later in relation to later priority dates.
The Delhi High Court upheld the Deputy Controller’s rejection, which is deemed as withdrawn application. The Court decided that
- Rule 20(4)(i) 31-month national phase entry time limit is strict and non-extendable.
- An applicant cannot avoid the earliest priority date by making amendments to avoid a non-discretionary deadline.
- If an error or negligence by a patent agent vests discretion in the Controller to extend discretionary absolute limitations such as under Rule 137, or Rule 138 outside their limited, prescribed window, then this is not what the Controller is looking for.
Key Practice Takeaway: In India, it's a death sentence if you fall behind the 31-month mark. In contrast, there are some countries around the world that have well-developed "intentional delay" restoration mechanisms as per PCT Rule 49.6, which is not the case in India.
Scenario | Route | Rationale |
1-2 Countries | Paris Convention | Immediate entry; total cost stays low as only 1-2 countries national filing needed. |
3+ Countries, Uncertain markets | PCT | Single filing fee upfront; defers larger multi-country cost to 30/31 months. |
3+ Countries, certain markets, budget ready | Paris Convention | NO PCT International-Phase fees layered on top: direct filing avoids that extra cost, not because its cheap overall. |
Startups with Uncertain Markets
The Scenarios : A deep-tech start-up has filed an initial provisional application in India but is still working on the software-as-a-service (SaaS) or hardware delivery model. They don't know which country (Germany, Japan or the U.S.) they will sell the most to.
The Strategy : PCT Route. This path does not have cash burn at the outset. It gives 31 months to prove product-market fit before paying foreign legal fees.
SMEs Entering 3+ Jurisdictions
The Scenario : The Medical Device Manufacturer is aware of their product having clear regulatory pathways, and viable markets in the US, EU, UK and India.
The Scenario : A company in the automotive components sector is looking to scale up production just from India to South Korea. They are not planning to scale anywhere else around the world.
One of the Strategies is the Paris Convention Route. The PCT application places an unnecessary and extra layer of international administrative burden. Filing directly in South Korea at month 12 will take a direct, faster path to grant in the country, without WIPO transmittal and search fees.
Conclusion
The debate on the PCT vs Paris Convention is not which is the best system, it is which is the best system for your corporate needs, your balance sheet and your corporate timeline.
The Paris Convention continues to be the fastest and cheapest method to highly targeted, focused market entry into one or two established foreign markets.
For companies that value asset flexibility, long term capital preservation and wide market protection across multiple jurisdictions, the PCT is a must.
Policy & Practice Takeaway: Compliance with national deadlines is key for corporate IP counsels and patent practitioners. The Delhi High Court in Neurocentria has affirmed that the national phase entry deadline for 31 months and the synchronized date for the 2024 Request for Examination are inflexible deadlines. Effective docketing guidelines should be used so that international options aren't lost because of administrative oversight by the portfolio managers.
Author :- Tanishka Gora, in case of any query, contact us at Global Patent Filing or write back us via email at support@globalpatentfiling.com.
Endnotes/ References
- Patent Cooperation Treaty (modified on October 3, 2001) arts 3, 4, 8, 22, 39
Domestic Statutes and Rules
- The Patents Act 1970 (India), ss 39, 57(5), 64(1)(m), 11B.
- The Patents Rules 2003 (India) (as amended by the Patents (Amendment) Rules 2024), r 20(4)(i), r 22, r 24B, r 138.
Case Law
- Neurocentria Inc. v Deputy Controller of Patents & Designs [2026] C.A. (COMM. IPD-PAT) 5/2025 (Delhi HC).
Institutional Manuals & Fee Schedules
- WIPO, PCT Applicant's Guide - International Phase (WIPO Publication 2025).
- Indian Patent Office, Comprehensive e-Filing Gateway and Official Fee Schedule (Comprehensive Regulatory Guidelines) https://ipindia.gov.in accessed July 2, 2026.